Heartcare Midwest
Peoria, Illinois 61637
0 studies enrolling now · 17 studies all time
What they study most
Acute Coronary Syndrome, Acute Coronary Syndrome (ACS), Angioplasty, Transluminal, Percutaneous Coronary, Aortic Aneurysm, Cardiovascular Diseases, Congestive Heart Failure, Descending Thoracic Aortic Aneurysm, Heart Diseases, Heart Failure, Heart Failure, Congestive, Pulmonary Arterial Hypertension, Pulmonary Embolism
Studies at this site
- ANCHOR (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry) — Completed
- A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure — Completed
- Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH — Stopped early
- An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension — Completed
- Zenith TX2® Post-market Approval Study — Completed
- Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy — Completed
- Quadripolar Pacing Post Approval Study — Completed
- MultiPoint Pacing IDE Study — Completed
- A Prospective, Multi-Center Study of the Bard® Denali™ Retrievable Inferior Vena Cava Filter System — Completed
- Phase III Acute Coronary Syndrome — Stopped early
- Safety Study of Apixaban in Recent Acute Coronary Syndrome — Completed
- Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function — Completed
- EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan — Completed
- Warfarin and Antiplatelet Therapy in Chronic Heart Failure — Completed
- The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention — Completed
- Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure. — Completed
- A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack — Stopped early